Comparing Sensitivity and Specificity of Addenbrooke’s Cognitive Examination-I, III and Mini-Addenbrooke’s Cognitive Examination in Parkinson’s Disease

Comparing Sensitivity and Specificity of Addenbrooke’s Cognitive Examination-I, III and Mini-Addenbrooke’s Cognitive Examination in Parkinson’s Disease

Background. Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by numerous motor and nonmotor symptoms. Neurocognitive disorders (NCD) are one of the most troublesome problems and their diagnosis is often challenging. Methods. We compared the sensitivity and...

Bibliografske podrobnosti
Main Authors:	Tivadar Lucza, Zsuzsanna Ascherman, Márton Kovács, Attila Makkos, Márk Harmat, Annamária Juhász, József Janszky, Sámuel Komoly, Norbert Kovács, Krisztina Dorn, Kázmér Karádi
Format:	Article
Jezik:	English
Izdano:	Wiley 2018-01-01
Serija:	Behavioural Neurology
Online dostop:	http://dx.doi.org/10.1155/2018/5932028

Podobne knjige/članki

Screening Mild and Major Neurocognitive Disorders in Parkinson’s Disease
od: Tivadar Lucza, et al.
Izdano: (2015-01-01)

Cut-off scores for mild and moderate dementia on the Addenbrooke's Cognitive Examination-III and the Mini-Addenbrooke's Cognitive Examination compared with the Mini-Mental State Examination
od: Louise McCarthy, et al.
Izdano: (2024-02-01)

Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson’s Disease
od: Márton Kovács, et al.
Izdano: (2016-01-01)

Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia
od: J.A. Matias-Guiu, et al.
Izdano: (2015-11-01)

Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R)
od: T. Torralva, et al.
Izdano: (2011-01-01)

A Validation Study of the Japanese Version of the Addenbrooke’s Cognitive Examination-Revised
od: Kelssy Hitomi dos Santos Kawata, et al.
Izdano: (2012-03-01)

Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan
od: Shintaro Takenoshita, et al.
Izdano: (2019-04-01)

The Addenbrooke’s Cognitive Examination III (ACE-III): linguistic and cultural adaptation into Russian
od: Natalia A. Varako, et al.
Izdano: (2022-01-01)

Guideline-conform translation and cultural adaptation of the Addenbrooke’s Cognitive Examination III into German
od: Weiss, Björn, et al.
Izdano: (2020-04-01)

Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review
od: Bruno D, et al.
Izdano: (2019-02-01)

Validation of the Addenbrooke’s Cognitive Examination III (ACE-III) in Alzheimer’s disease and Mild Cognitive Impairment
od: Majid Mahmoud alilou, et al.
Izdano: (2019-04-01)

Validation of the Malay Version of Addenbrooke’s Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia
od: Kan, Kwai Ching, et al.
Izdano: (2019)

Screening for Problematic Internet Use May Help Identify Impulse Control Disorders in Parkinson’s Disease
od: Márton Kovács, et al.
Izdano: (2019-01-01)

Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease
od: Márton Kovács, et al.
Izdano: (2017-01-01)

Use of Addenbrooke’s cognitive examination-revised to evaluate the patients’ state in general medical practice
od: Nikolai Nikolayevich Ivanets, et al.
Izdano: (2012-03-01)

Exploring the impact of thyroid disorders on cognitive domains with Mini Addenbrooke's Cognitive Examination: A prospective study
od: Sona P Sam, et al.
Izdano: (2024-01-01)

Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease
od: Nariana Mattos Figueiredo Sousa, et al.
Izdano: (2023-02-01)

Validation of a modified Chinese version of Mini‐Addenbrooke's Cognitive Examination for detecting mild cognitive impairment
od: Feng‐Feng Pan, et al.
Izdano: (2022-01-01)

Minimal Clinically Important Difference on Parkinson’s Disease Sleep Scale 2nd Version
od: Krisztina Horváth, et al.
Izdano: (2015-01-01)

Diagnóstico diferencial de envejecimiento patológico. Desempeños en el Addenbrooke's Cognitive Examination (ACE)
od: María Laura de la Barrera, et al.
Izdano: (2009-01-01)

Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
od: Carlos Calderón, et al.
Izdano: (2021-01-01)

A validation study of the Chinese-Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER)
od: Wong LL, et al.
Izdano: (2013-06-01)

Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia
od: D. Bruno, et al.
Izdano: (2020-03-01)

Performance of low-educated elders with depression on Addenbrooke's Cognitive Examination-Revised (ace-r) test
od: Michele Beckert, et al.

Improving the quality of cognitive screening assessments: ACEmobile, an iPad‐based version of the Addenbrooke's Cognitive Examination‐III
od: Craig G.J. Newman, et al.
Izdano: (2018-01-01)

Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level
od: Maria Sheila Guimarães Rocha, et al.

Detecting cognitive impairment in patients with Parkinson's disease using a brief cognitive screening tool: Addenbrooke's Cognitive Examination (ACE)
od: Anabel Chade, et al.

Addenbrooke’s Cognitive Examination and Individual Domain Cut-Off Scores for Discriminating between Different Cognitive Subtypes of Parkinson’s Disease
od: Dagmar Berankova, et al.
Izdano: (2015-01-01)

Development of the Brazilian version of the Mini-Addenbrooke Cognitive Examination (M-ACE BR) to screen for cognitive impairment in older adults
od: Maira Okada-Oliveira, et al.
Izdano: (2024-08-01)

Video teleconference administration of the addenbrooke's cognitive examination-III for the assessment of neuropsychological status: An experience in Indian subjects with cognitive dysfunction
od: Garima Saini, et al.
Izdano: (2023-01-01)

The Utility of the Mini-Addenbrooke’s Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and Diabetes
od: Peter Hobson, et al.
Izdano: (2016-12-01)

The Mini-Addenbrooke’s Cognitive Examination (M-ACE) as a brief cognitive screening instrument in Mild Cognitive Impairment and mild Alzheimer’s disease
od: Diane da Costa Miranda, et al.

Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised
od: Emmanuelle Sobreira, et al.
Izdano: (2015-11-01)

FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
od: María Nieves Cabrera-Martín, et al.
Izdano: (2023-11-01)

Does the Order of Item Difficulty of the Addenbrooke's Cognitive Examination Add Anything to Subdomain Scores in the Clinical Assessment of Dementia
od: Sarah McGrory, et al.
Izdano: (2015-04-01)

Hindi Version of Addenbrooke’s Cognitive Examination III: Distinguishing Cognitive Impairment Among Older Indians at the Lower Cut-Offs
od: Bajpai S, et al.
Izdano: (2020-03-01)

Deep Brain Stimulation Can Preserve Working Status in Parkinson’s Disease
od: Gabriella Deli, et al.
Izdano: (2015-01-01)

Developing and implementing guidelines on culturally adapting the Addenbrooke’s cognitive examination version III (ACE-III): a qualitative illustration
od: Waquas Waheed, et al.
Izdano: (2020-10-01)

Cultural validation of the Addenbrooke’s Cognitive Examination Version III Urdu for the British Urdu-speaking population: a qualitative assessment using cognitive interviewing
od: Nadine Mirza, et al.
Izdano: (2018-12-01)

21182. VALIDACIÓN DEL TEST MINI-ADDENBROOKE'S COGNITIVE EXAMINATION EN FASES PRECOCES DE LA ENFERMEDAD DE ALZHEIMER
od: P. Abizanda Saro, et al.
Izdano: (2024-11-01)